{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:27:22Z","timestamp":1746332842800},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["568773"],"award-info":[{"award-number":["568773"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Health Service Research Program Grant"],"award-info":[{"award-number":["Health Service Research Program Grant"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clncl Oncology"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Routine data collections are used increasingly to examine outcomes of real\u2010world cancer drug use. These datasets lack clinical details about important endpoints such as disease progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To validate a proxy for disease progression in metastatic cancer patients using prescribing and dispensing claims.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data from a cohort study of patients undergoing chemotherapy who provided informed consent to the collection of cancer\u2010treatment data from medical records and linkage to pharmaceutical claims. We derived proxy decision rules based on changes to drug treatment in prescription histories (<jats:italic>n<\/jats:italic> = 36 patients) and validated the proxy in prescribing data (<jats:italic>n<\/jats:italic> = 62 patients). We adapted the decision rules and validated the proxy in dispensing data (<jats:italic>n<\/jats:italic> = 109). Our gold standard was disease progression ascertained in patient medical records. Individual progression episodes were the unit of analysis for sensitivity and Positive Predictive Value (PPV) calculations and specificity and Negative Predictive Value (NPV) were calculated at the patient level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The sensitivity of our proxy in prescribing data was 74.3% (95% Confidence Interval (CI), 55.6\u201386.6%) and PPV 61.2% (95% CI, 45.0\u201375.3%); specificity and NPV were 87.8% (95% CI, 73.8\u201395.9%) and 100% (95% CI, 90.3\u2013100%), respectively. In dispensing data, the sensitivity of our proxy was 64% (95% CI, 55.0\u201377.0%) and PPV 56.0% (95% CI, 43.0\u201369.0%); specificity and NPV were 81% (95% CI, 70.05\u201389.0%) and 91.0% (95% CI, 82.0\u201397.0%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our proxy overestimated episodes of disease progression. The proxy's performance is likely to improve if the date of prescribing is used instead of date of dispensing in claims data and by incorporating medical service claims (such as imaging prior to drug changes) in the algorithm. Our proxy is not sufficiently robust for use in real world comparative effectiveness research for cancer medicines.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajco.12602","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T09:46:47Z","timestamp":1474883207000},"source":"Crossref","is-referenced-by-count":3,"title":["Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data"],"prefix":"10.1111","volume":"13","author":[{"given":"Vikram","family":"Joshi","sequence":"first","affiliation":[{"name":"Prince of Wales Clinical School Faculty of Medicine University of New South Wales  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara\u2010Ann","family":"Adelstein","sequence":"additional","affiliation":[{"name":"Prince of Wales Clinical School Faculty of Medicine University of New South Wales  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schaffer","sequence":"additional","affiliation":[{"name":"Prince of Wales Clinical School Faculty of Medicine University of New South Wales  Sydney Australia"},{"name":"Faculty of Pharmacy University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeyaporn","family":"Srasuebkul","sequence":"additional","affiliation":[{"name":"Prince of Wales Clinical School Faculty of Medicine University of New South Wales  Sydney Australia"},{"name":"Faculty of Pharmacy University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Dobbins","sequence":"additional","affiliation":[{"name":"School of Public Health Sydney Medical School University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie\u2010Anne","family":"Pearson","sequence":"additional","affiliation":[{"name":"Prince of Wales Clinical School Faculty of Medicine University of New South Wales  Sydney Australia"},{"name":"Faculty of Pharmacy University of Sydney  Sydney Australia"},{"name":"School of Public Health Sydney Medical School University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Elements of Cancer Care (EoCC) Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_10_2_1","DOI":"10.1056\/NEJMra1204479"},{"doi-asserted-by":"publisher","key":"e_1_2_10_3_1","DOI":"10.1056\/NEJMp0706892"},{"doi-asserted-by":"publisher","key":"e_1_2_10_4_1","DOI":"10.1200\/JCO.2011.38.6359"},{"doi-asserted-by":"publisher","key":"e_1_2_10_5_1","DOI":"10.1602\/neurorx.1.2.189"},{"doi-asserted-by":"publisher","key":"e_1_2_10_6_1","DOI":"10.1016\/j.jclinepi.2004.10.012"},{"doi-asserted-by":"publisher","key":"e_1_2_10_7_1","DOI":"10.1097\/MLR.0b013e31805371bf"},{"doi-asserted-by":"publisher","key":"e_1_2_10_8_1","DOI":"10.1016\/j.jclinepi.2010.10.006"},{"doi-asserted-by":"publisher","key":"e_1_2_10_9_1","DOI":"10.1016\/j.jclinepi.2007.05.017"},{"doi-asserted-by":"publisher","key":"e_1_2_10_10_1","DOI":"10.1097\/00005650-199907000-00010"},{"doi-asserted-by":"publisher","key":"e_1_2_10_11_1","DOI":"10.1007\/s11060-009-9943-z"},{"doi-asserted-by":"publisher","key":"e_1_2_10_12_1","DOI":"10.1016\/S0895-4356(99)00173-0"},{"key":"e_1_2_10_13_1","first-page":"237","article-title":"Comparing methods for identifying pancreatic cancer patients using electronic data sources","volume":"2010","author":"Friedlin J","year":"2010","journal-title":"AMIA Annu Symp Proc"},{"doi-asserted-by":"publisher","key":"e_1_2_10_14_1","DOI":"10.1016\/S0895-4356(98)00143-7"},{"doi-asserted-by":"publisher","key":"e_1_2_10_15_1","DOI":"10.1111\/j.1475-6773.2004.00315.x"},{"doi-asserted-by":"publisher","key":"e_1_2_10_16_1","DOI":"10.1002\/pds.3247"},{"doi-asserted-by":"publisher","key":"e_1_2_10_17_1","DOI":"10.1097\/01.mlr.0000167176.41645.c7"},{"doi-asserted-by":"publisher","key":"e_1_2_10_18_1","DOI":"10.1007\/BF00999321"},{"doi-asserted-by":"publisher","key":"e_1_2_10_19_1","DOI":"10.1097\/MLR.0b013e318289c3fb"},{"doi-asserted-by":"publisher","key":"e_1_2_10_20_1","DOI":"10.1200\/JCO.2007.11.2516"},{"doi-asserted-by":"publisher","key":"e_1_2_10_21_1","DOI":"10.1093\/biostatistics\/kxm052"},{"doi-asserted-by":"publisher","key":"e_1_2_10_22_1","DOI":"10.1002\/pds.2257"},{"doi-asserted-by":"publisher","key":"e_1_2_10_23_1","DOI":"10.1111\/j.1475-6773.2007.00705.x"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12602","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12602","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajco.12602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T02:46:41Z","timestamp":1696042001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.12602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/ajco.12602"],"URL":"https:\/\/doi.org\/10.1111\/ajco.12602","archive":["Portico"],"relation":{},"ISSN":["1743-7555","1743-7563"],"issn-type":[{"type":"print","value":"1743-7555"},{"type":"electronic","value":"1743-7563"}],"subject":[],"published":{"date-parts":[[2016,9,26]]}}}